Covered recipient · General Payments record
TIMOTHY CHEN
Allopathic & Osteopathic Physicians Internal Medicine Infectious Disease
General Payments · PY2018–2024
$6,370.20
- Reported across 340 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $790.55 | 34 |
| Education | $75.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $509.58 | 22 |
| Astellas Pharma US Inc | $132.36 | 4 |
| Insmed, Inc. | $106.81 | 4 |
| Gilead Sciences, Inc. | $44.77 | 2 |
| Melinta Therapeutics, Inc. | $25.43 | 1 |
| Shionogi Inc | $23.34 | 1 |
| Merck Sharp & Dohme Corporation | $23.26 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.41 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103453770 | CMS |
| ABBVIE INC. | $14.65 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103453772 | CMS |
| ABBVIE INC. | $24.51 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103453774 | CMS |
| ABBVIE INC. | $22.01 | 03/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103453776 | CMS |
| ABBVIE INC. | $25.84 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103453778 | CMS |
| ABBVIE INC. | $23.27 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103453780 | CMS |
| ABBVIE INC. | $27.32 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103453782 | CMS |
| ABBVIE INC. | $13.47 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103453784 | CMS |
| ABBVIE INC. | $23.85 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103453786 | CMS |
| ABBVIE INC. | $16.74 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103453788 | CMS |
| ABBVIE INC. | $23.27 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103453790 | CMS |
| ABBVIE INC. | $23.81 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103453792 | CMS |
| ABBVIE INC. | $21.29 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103453794 | CMS |
| ABBVIE INC. | $28.57 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103453796 | CMS |
| ABBVIE INC. | $29.43 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103453798 | CMS |
| ABBVIE INC. | $32.89 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103453800 | CMS |
| ABBVIE INC. | $29.34 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103453802 | CMS |
| ABBVIE INC. | $24.61 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103453804 | CMS |
| ABBVIE INC. | $29.89 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103453806 | CMS |
| ABBVIE INC. | $1.50 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103453808 | CMS |
| ABBVIE INC. | $27.62 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103453810 | CMS |
| ABBVIE INC. | $23.29 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103453812 | CMS |
| Astellas Pharma US Inc | $16.24 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139263502 | CMS |
| Astellas Pharma US Inc | $17.75 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139297804 | CMS |
| Astellas Pharma US Inc | $23.37 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139324990 | CMS |
| Astellas Pharma US Inc | $75.00 | 05/23/2024 | Education | Undisputed | 01/23/2026 | 1139349256 | CMS |
| Gilead Sciences, Inc. | $21.20 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133643022 | CMS |
| Gilead Sciences, Inc. | $23.57 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133643024 | CMS |
| Insmed, Inc. | $26.51 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089577528 | CMS |
| Insmed, Inc. | $24.30 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089573314 | CMS |
| Insmed, Inc. | $27.52 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089576316 | CMS |
| Insmed, Inc. | $28.48 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089577266 | CMS |
| Melinta Therapeutics, LLC | $25.43 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140485041 | CMS |
| Merck Sharp & Dohme LLC | $23.26 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141876492 | CMS |
| Shionogi Inc | $23.34 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154333994 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.